|
Gene: COTL1 |
Gene summary for COTL1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | COTL1 | Gene ID | 23406 |
Gene name | coactosin like F-actin binding protein 1 | |
Gene Alias | CLP | |
Cytomap | 16q24.1 | |
Gene Type | protein-coding | GO ID | GO:0002376 | UniProtAcc | Q14019 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23406 | COTL1 | GSM4909281 | Human | Breast | IDC | 9.83e-32 | 7.82e-01 | 0.21 |
23406 | COTL1 | GSM4909286 | Human | Breast | IDC | 3.72e-03 | -2.36e-01 | 0.1081 |
23406 | COTL1 | GSM4909290 | Human | Breast | IDC | 1.25e-02 | -2.47e-01 | 0.2096 |
23406 | COTL1 | GSM4909297 | Human | Breast | IDC | 1.21e-05 | -2.28e-01 | 0.1517 |
23406 | COTL1 | GSM4909301 | Human | Breast | IDC | 3.22e-03 | -2.20e-01 | 0.1577 |
23406 | COTL1 | GSM4909307 | Human | Breast | IDC | 5.71e-08 | -2.84e-01 | 0.1569 |
23406 | COTL1 | GSM4909308 | Human | Breast | IDC | 1.35e-07 | -2.83e-01 | 0.158 |
23406 | COTL1 | GSM4909309 | Human | Breast | IDC | 9.13e-04 | -2.31e-01 | 0.0483 |
23406 | COTL1 | GSM4909311 | Human | Breast | IDC | 1.69e-10 | -2.90e-01 | 0.1534 |
23406 | COTL1 | GSM4909312 | Human | Breast | IDC | 3.69e-10 | -2.80e-01 | 0.1552 |
23406 | COTL1 | GSM4909319 | Human | Breast | IDC | 5.62e-10 | -2.53e-01 | 0.1563 |
23406 | COTL1 | GSM4909320 | Human | Breast | IDC | 8.65e-03 | -2.90e-01 | 0.1575 |
23406 | COTL1 | GSM4909321 | Human | Breast | IDC | 2.97e-07 | -2.72e-01 | 0.1559 |
23406 | COTL1 | brca1 | Human | Breast | Precancer | 1.01e-43 | 8.42e-01 | -0.0338 |
23406 | COTL1 | brca3 | Human | Breast | Precancer | 7.17e-05 | 2.62e-01 | -0.0263 |
23406 | COTL1 | NCCBC14 | Human | Breast | DCIS | 1.83e-03 | 2.51e-02 | 0.2021 |
23406 | COTL1 | NCCBC3 | Human | Breast | DCIS | 6.05e-12 | 4.79e-01 | 0.1198 |
23406 | COTL1 | NCCBC5 | Human | Breast | DCIS | 3.73e-12 | 4.59e-01 | 0.2046 |
23406 | COTL1 | P1 | Human | Breast | IDC | 6.16e-07 | -8.45e-02 | 0.1527 |
23406 | COTL1 | DCIS2 | Human | Breast | DCIS | 5.62e-29 | 4.52e-02 | 0.0085 |
Page: 1 2 3 4 5 6 7 8 9 10 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0110053111 | Skin | cSCC | regulation of actin filament organization | 103/4864 | 278/18723 | 2.78e-05 | 3.12e-04 | 103 |
GO:003295629 | Skin | cSCC | regulation of actin cytoskeleton organization | 127/4864 | 358/18723 | 3.83e-05 | 4.13e-04 | 127 |
GO:0008154110 | Skin | cSCC | actin polymerization or depolymerization | 81/4864 | 218/18723 | 1.70e-04 | 1.47e-03 | 81 |
GO:0032535111 | Skin | cSCC | regulation of cellular component size | 131/4864 | 383/18723 | 1.89e-04 | 1.59e-03 | 131 |
GO:0008064110 | Skin | cSCC | regulation of actin polymerization or depolymerization | 71/4864 | 188/18723 | 2.38e-04 | 1.95e-03 | 71 |
GO:0030832110 | Skin | cSCC | regulation of actin filament length | 71/4864 | 189/18723 | 2.86e-04 | 2.28e-03 | 71 |
GO:003004124 | Skin | cSCC | actin filament polymerization | 68/4864 | 191/18723 | 1.98e-03 | 1.18e-02 | 68 |
GO:003083325 | Skin | cSCC | regulation of actin filament polymerization | 62/4864 | 172/18723 | 2.18e-03 | 1.29e-02 | 62 |
GO:00070156 | Stomach | GC | actin filament organization | 67/1159 | 442/18723 | 7.96e-12 | 2.20e-09 | 67 |
GO:00432546 | Stomach | GC | regulation of protein-containing complex assembly | 58/1159 | 428/18723 | 1.48e-08 | 1.32e-06 | 58 |
GO:19029036 | Stomach | GC | regulation of supramolecular fiber organization | 53/1159 | 383/18723 | 3.07e-08 | 2.39e-06 | 53 |
GO:00329706 | Stomach | GC | regulation of actin filament-based process | 54/1159 | 397/18723 | 4.11e-08 | 2.85e-06 | 54 |
GO:01100536 | Stomach | GC | regulation of actin filament organization | 41/1159 | 278/18723 | 2.00e-07 | 1.11e-05 | 41 |
GO:00329566 | Stomach | GC | regulation of actin cytoskeleton organization | 48/1159 | 358/18723 | 3.57e-07 | 1.88e-05 | 48 |
GO:00512586 | Stomach | GC | protein polymerization | 38/1159 | 297/18723 | 1.72e-05 | 5.40e-04 | 38 |
GO:00322716 | Stomach | GC | regulation of protein polymerization | 32/1159 | 233/18723 | 1.90e-05 | 5.83e-04 | 32 |
GO:00081546 | Stomach | GC | actin polymerization or depolymerization | 30/1159 | 218/18723 | 3.29e-05 | 8.94e-04 | 30 |
GO:00300416 | Stomach | GC | actin filament polymerization | 27/1159 | 191/18723 | 4.99e-05 | 1.19e-03 | 27 |
GO:00325355 | Stomach | GC | regulation of cellular component size | 44/1159 | 383/18723 | 5.66e-05 | 1.31e-03 | 44 |
GO:00080646 | Stomach | GC | regulation of actin polymerization or depolymerization | 26/1159 | 188/18723 | 9.89e-05 | 2.00e-03 | 26 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
COTL1 | SNV | Missense_Mutation | c.144N>G | p.Phe48Leu | p.F48L | Q14019 | protein_coding | tolerated(0.18) | benign(0.408) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
COTL1 | SNV | Missense_Mutation | c.398G>T | p.Gly133Val | p.G133V | Q14019 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
COTL1 | SNV | Missense_Mutation | rs750865355 | c.256G>A | p.Val86Ile | p.V86I | Q14019 | protein_coding | tolerated(0.12) | benign(0.043) | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD |
COTL1 | SNV | Missense_Mutation | novel | c.221N>T | p.Ser74Phe | p.S74F | Q14019 | protein_coding | tolerated(0.1) | benign(0.224) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
COTL1 | SNV | Missense_Mutation | novel | c.338T>C | p.Val113Ala | p.V113A | Q14019 | protein_coding | tolerated(0.51) | benign(0.087) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
COTL1 | SNV | Missense_Mutation | rs374406128 | c.422N>T | p.Thr141Met | p.T141M | Q14019 | protein_coding | tolerated_low_confidence(0.16) | benign(0.003) | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
COTL1 | SNV | Missense_Mutation | c.284N>A | p.Gly95Glu | p.G95E | Q14019 | protein_coding | deleterious(0.01) | possibly_damaging(0.478) | TCGA-44-3917-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
COTL1 | SNV | Missense_Mutation | rs755533045 | c.188N>C | p.Arg63Pro | p.R63P | Q14019 | protein_coding | deleterious(0) | probably_damaging(0.98) | TCGA-53-7624-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | PD |
COTL1 | SNV | Missense_Mutation | rs749367597 | c.287N>T | p.Thr96Met | p.T96M | Q14019 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-55-8506-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
COTL1 | SNV | Missense_Mutation | rs749367597 | c.287N>T | p.Thr96Met | p.T96M | Q14019 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CQ-A4C9-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |